The issue is that there are too many barriers to commercialisation and the current stakeholders have too much power. The profitable fields like medicine strictly limit the number of people accepted (the official explanation is that there aren't enough residencies, the unspoken reason is that the American Medical Association wants to keep salaries up) and FDA drug approval laws err on the side of caution; better to have 10 people die due to disease and lack of access to treatments than to have one person die due to a faulty drug that the FDA let through. This attitude and approach means that the time to market is huge and highly resource intensive. The COVID vaccines were designed in less than a day. It took a year to reach market even under the ridiculously accelerated approval pace.